Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will participate in three investor conferences this November. The Jefferies London Healthcare Conference is on November 15, 2022 at 5:20 a.m. ET. The 5th Annual Evercore ISI HealthCONx Conference follows on November 29, 2022 at 1:50 p.m. ET. Finally, the Piper Sandler 34th Annual Healthcare Conference will occur on November 30, 2022 at 12:00 p.m. ET. Audio webcasts of the presentations will be available on their website, archived for 30 days.

DUBLIN, Nov. 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in the following upcoming investor conferences:

Jefferies London Healthcare Conference on Tuesday, November 15, 2022  

• The presentation is scheduled for 5:20 a.m. ET / 10:20 a.m. GMT.

5^th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022

• The presentation is scheduled for 1:50 p.m. ET / 6:50 p.m. GMT.

Piper Sandler 34^th Annual Healthcare Conference on Wednesday, November 30, 2022

• The presentation is scheduled for 12:00 p.m. ET / 5:00 p.m. GMT.

Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Replays of the webcasts will be archived on the website for 30 days following the conferences.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-november-investor-conferences-301665345.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals present at the Jefferies London Healthcare Conference?

Jazz Pharmaceuticals will present at the Jefferies London Healthcare Conference on November 15, 2022, at 5:20 a.m. ET.

What is the schedule for Jazz Pharmaceuticals at the Evercore ISI HealthCONx Conference?

Jazz Pharmaceuticals' presentation at the 5th Annual Evercore ISI HealthCONx Conference is on November 29, 2022, at 1:50 p.m. ET.

When will Jazz Pharmaceuticals be at the Piper Sandler Healthcare Conference?

Jazz Pharmaceuticals will present at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 12:00 p.m. ET.

Where can I find the audio webcasts for Jazz Pharmaceuticals' investor presentations?

Audio webcasts of Jazz Pharmaceuticals' presentations will be available on their Investors section of the website and archived for 30 days.

What is the purpose of Jazz Pharmaceuticals as a company?

Jazz Pharmaceuticals aims to innovate and develop life-changing medicines for patients with serious diseases, often providing new therapeutic options.